New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers find unexpected connection between SARS-CoV-2 and fragile X syndrome

Researchers find unexpected connection between SARS-CoV-2 and fragile X syndrome

FEBRUARY 27, 2024byUniversity of CopenhagenCredit: CC0 Public DomainHow does coronavirus spread through the body? A new study,availableon the preprint serverbioRxiv, can help u
Breakthroughs March 28,2024
Researchers find unexpected connection between SARS-CoV-2 and fragile X syndrome

Researchers find unexpected connection between SARS-CoV-2 and fragile X syndrome

FEBRUARY 27, 2024byUniversity of CopenhagenCredit: CC0 Public DomainHow does coronavirus spread through the body? A new study,availableon the preprint serverbioRxiv, can help u
Breakthroughs March 28,2024
New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

by Brigham and Women’s HospitalGraphical abstract. Credit:Circulation Research(2024). DOI: 10.1161/CIRCRESAHA.123.323623When people hear about predicting heart disease, most will thin
Cardiovascular Diseases March 28,2024
New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

by Brigham and Women’s HospitalGraphical abstract. Credit:Circulation Research(2024). DOI: 10.1161/CIRCRESAHA.123.323623When people hear about predicting heart disease, most will thin
Cardiovascular Diseases March 28,2024
Breast milk may have potential protective effects against SARS-CoV-2, say researchers

Breast milk may have potential protective effects against SARS-CoV-2, say researchers

JANUARY 29, 2024by Betty Zou,University of TorontoCredit: Pixabay/CC0 Public DomainThe COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.The uncertainties ab
OB & GYN March 28,2024
Breast milk may have potential protective effects against SARS-CoV-2, say researchers

Breast milk may have potential protective effects against SARS-CoV-2, say researchers

JANUARY 29, 2024by Betty Zou,University of TorontoCredit: Pixabay/CC0 Public DomainThe COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.The uncertainties ab
OB & GYN March 28,2024
New research finds half-cardio, half-strength training reduces cardiovascular disease risks

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero
Cardiovascular Diseases March 28,2024
New research finds half-cardio, half-strength training reduces cardiovascular disease risks

New research finds half-cardio, half-strength training reduces cardiovascular disease risks

by Iowa State UniversityStructured Graphical Abstract Effects of 1-year resistance, aerobic, or combined exercise training on cardiovascular disease (CVD) risk profile: the CardioRACE trial. Aero
Cardiovascular Diseases March 28,2024
Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105
Oncology March 28,2024
Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105
Oncology March 28,2024
A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d
Oncology March 28,2024
A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d
Oncology March 28,2024
Research team discovers potential Alzheimer's drug

Research team discovers potential Alzheimer's drug

FEBRUARY 6, 2024by University of Arkansas for Medical SciencesMolecular docking predicts a CLEAR DNA-binding region in ApoE4. a The DNA-binding region of ApoE4, as defined by molecular modeling. b The
Breakthroughs March 28,2024
Research team discovers potential Alzheimer's drug

Research team discovers potential Alzheimer's drug

FEBRUARY 6, 2024by University of Arkansas for Medical SciencesMolecular docking predicts a CLEAR DNA-binding region in ApoE4. a The DNA-binding region of ApoE4, as defined by molecular modeling. b The
Breakthroughs March 28,2024
New study suggests target steps per day for reduced risk of heart failure

New study suggests target steps per day for reduced risk of heart failure

by University at BuffaloCredit: Pixabay/CC0 Public DomainThe science is clear that movement is good for our bodies as we age. But just how much physical activity is beneficial for people over 60?
Cardiovascular Diseases March 28,2024
New study suggests target steps per day for reduced risk of heart failure

New study suggests target steps per day for reduced risk of heart failure

by University at BuffaloCredit: Pixabay/CC0 Public DomainThe science is clear that movement is good for our bodies as we age. But just how much physical activity is beneficial for people over 60?
Cardiovascular Diseases March 28,2024
Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

FEBRUARY 5, 2024by Higher Education PressWorkflow to perform snRNA-seq of different WAT depots. The nuclei were derived from subcutaneous (S), epididymal (E), mesenteric (M), peri-nephritic (N), and p
Breakthroughs March 28,2024
Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

Team develops a single-nucleus resolution atlas of white adipose tissue in different depots

FEBRUARY 5, 2024by Higher Education PressWorkflow to perform snRNA-seq of different WAT depots. The nuclei were derived from subcutaneous (S), epididymal (E), mesenteric (M), peri-nephritic (N), and p
Breakthroughs March 28,2024
Researchers halt progression of Parkinson's disease in mouse model

Researchers halt progression of Parkinson's disease in mouse model

NOVEMBER 14, 2023by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterGeneration and characterization of Usp30 KO mice. a Schematic of gene targeting to generate the Usp30 KO mice. b Bar g
Breakthroughs March 28,2024
Researchers halt progression of Parkinson's disease in mouse model

Researchers halt progression of Parkinson's disease in mouse model

NOVEMBER 14, 2023by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterGeneration and characterization of Usp30 KO mice. a Schematic of gene targeting to generate the Usp30 KO mice. b Bar g
Breakthroughs March 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com